Cargando…

Plasminogen Activator Inhibitor-1 in depression: Results from Animal and Clinical Studies

Evidence suggests that plasminogen activator inhibitor-1 (PAI-1) is a stress-related factor, and serum PAI-1 levels are increased in patients with major depressive disorders (MDD). Herein, we analysed PAI-1 protein levels in the brain, cerebrospinal fluid (CSF) and serum of rodents exposed to chroni...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Haitang, Li, Xiaoli, Chen, Suzhen, Lu, Na, Yue, Yingying, Liang, Jinfeng, Zhang, Zhijun, Yuan, Yonggui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4960524/ https://www.ncbi.nlm.nih.gov/pubmed/27456456 http://dx.doi.org/10.1038/srep30464

Ejemplares similares

The Role of Neuropeptide Y mRNA Expression Level in Distinguishing Different Types of Depression
por: Yue, Yingying, et al.
Publicado: (2016)

The protein and mRNA expression levels of glial cell line-derived neurotrophic factor in post stroke depression and major depressive disorder
por: Zhang, Yanran, et al.
Publicado: (2017)

Towards a multi protein and mRNA expression of biological predictive and distinguish model for post stroke depression
por: Yue, Yingying, et al.
Publicado: (2016)

Abnormal Functional Connectivity of Amygdala in Late-Onset Depression Was Associated with Cognitive Deficits
por: Yue, Yingying, et al.
Publicado: (2013)

Combined serum IL-6, C-reactive protein, and cortisol may distinguish patients with anhedonia in major depressive disorder
por: Li, Yinghui, et al.
Publicado: (2022)

A risk prediction model for post-stroke depression in Chinese stroke survivors based on clinical and socio-psychological features
por: Liu, Rui, et al.
Publicado: (2017)

The Combination of Serum BDNF, Cortisol and IFN-Gamma Can Assist the Diagnosis of Major Depressive Disorder
por: Chen, Suzhen, et al.
Publicado: (2021)

Serum BICC1 levels are significantly different in various mood disorders
por: Chen, Suzhen, et al.
Publicado: (2019)

Structural basis of specific inhibition of tissue-type plasminogen activator by plasminogen activators inhibitor-1
por: Gong, Lihu, et al.
Publicado: (2016)

Role of tissue-type plasminogen activator and plasminogen activator inhibitor-1 in psychological stress and depression
por: Tsai, Shih-Jen
Publicado: (2017)

Neuroimaging studies of depressive disorders in China since 2000
por: YIN, Yingying, et al.
Publicado: (2014)

Clinical Efficacy of the Chinese Herbal Medicine Shumian Capsule for Insomnia: A Randomized, Double-Blind, Placebo-Controlled Trial
por: Chen, Suzhen, et al.
Publicado: (2022)

Spatio‐temporal graph convolutional network for diagnosis and treatment response prediction of major depressive disorder from functional connectivity
por: Kong, Youyong, et al.
Publicado: (2021)

COMT Val158Met Polymorphism Influences the Cerebral Blood Flow Changes Related to Psychomotor Retardation in Major Depressive Disorder
por: Yin, Yingying, et al.
Publicado: (2022)

A Predictive Model of Risk Factors for Conversion From Major Depressive Disorder to Bipolar Disorder Based on Clinical Characteristics and Circadian Rhythm Gene Polymorphisms
por: Xu, Zhi, et al.
Publicado: (2022)

Localization of Urokinase‐type Plasminogen Activator, Plasminogen Activator Inhibitor‐1, 2 and Plasminogen in Colon Cancer
por: Naitoh, Hiroyuki, et al.
Publicado: (1995)

Plasminogen Activator Inhibitor-1: Potential Inflammatory Marker in Late-life Depression
por: Lee, Seung-Hoon, et al.
Publicado: (2023)

CACNA1C Gene rs11832738 Polymorphism Influences Depression Severity by Modulating Spontaneous Activity in the Right Middle Frontal Gyrus in Patients With Major Depressive Disorder
por: Liu, Xiaoyun, et al.
Publicado: (2020)

Frequency-Dependent Amplitude Alterations of Resting-State Spontaneous Fluctuations in Late-Onset Depression
por: Yue, Yingying, et al.
Publicado: (2015)

PS188. Predict value of functional topological features for early response to antidepressant treatment in major depressive disorder
por: Hou, Zhenghua, et al.
Publicado: (2016)

Abnormal Functional Connectivity of Ventral Anterior Insula in Asthmatic Patients with Depression
por: Zhang, Yuqun, et al.
Publicado: (2017)

Divergent topological architecture of the default mode network as a pretreatment predictor of early antidepressant response in major depressive disorder
por: Hou, Zhenghua, et al.
Publicado: (2016)

Altered Regional Cerebral Blood Flow of Right Cerebellum Posterior Lobe in Asthmatic Patients With or Without Depressive Symptoms
por: Zhang, Yuqun, et al.
Publicado: (2018)

miR-30c may serve a role in endometriosis by targeting plasminogen activator inhibitor-1
por: Chen, Xiaoli, et al.
Publicado: (2017)

Plasminogen Activator Inhibitor-1 (PAI-1) deficiency predisposes to depression and resistance to treatments
por: Party, Hélène, et al.
Publicado: (2019)

Clinical significance of measuring plasminogen activator inhibitor-1 in sepsis
por: Iba, Toshiaki, et al.
Publicado: (2017)

PS187. Association analysis of imbalanced interhemispheric functional coordination and early therapeutic efficacy in major depressive disorder: evidence from resting state fMRI.
por: Hou, Zhenghua, et al.
Publicado: (2016)

Plasminogen Activator Inhibitor-1 Potentiates Neutrophil Infiltration and Tissue Injury in Colitis
por: Wang, Xinqiong, et al.
Publicado: (2023)

The effects of residual platelets in plasma on plasminogen activator inhibitor-1 and plasminogen activator inhibitor-1-related assays
por: Pieters, Marlien, et al.
Publicado: (2017)

Thrombin and plasmin generation in patients with plasminogen or plasminogen activator inhibitor type 1 deficiency
por: Saes, Joline L., et al.
Publicado: (2019)

Dopamine Multilocus Genetic Profile, Spontaneous Activity of Left Superior Temporal Gyrus, and Early Therapeutic Effect in Major Depressive Disorder
por: Liu, Xiaoyun, et al.
Publicado: (2020)

Tissue Plasminogen Activator and Plasminogen Activator Inhibitor 1 Contribute to Sonic Hedgehog-Induced In Vitro Cerebral Angiogenesis
por: Teng, Hua, et al.
Publicado: (2012)

Plasminogen Activator Inhibitor-1 Protects Mice Against Cardiac Fibrosis by Inhibiting Urokinase-type Plasminogen Activator-mediated Plasminogen Activation
por: Gupta, Kamlesh K., et al.
Publicado: (2017)

Retraction: The effects of residual platelets in plasma on plasminogen activator inhibitor-1 and plasminogen activator inhibitor-1-related assays
Publicado: (2018)

Vitamin D Deficiency is Associated With Increased Plasminogen Activator Inhibitor 1/Plasminogen Activator Inhibitor 2 Ratio in Pregnancy
por: Andersen, Matilde Kanstrup, et al.
Publicado: (2023)

Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 Levels in Patients with Acute Paraquat Intoxication
por: Seok, Su-Jin, et al.
Publicado: (2011)

Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients
por: Zuo, Yu, et al.
Publicado: (2021)

Mediating Role of the Reward Network in the Relationship between the Dopamine Multilocus Genetic Profile and Depression
por: Gong, Liang, et al.
Publicado: (2017)

New opinion on the subtypes of poststroke depression in Chinese stroke survivors
por: Yue, Yingying, et al.
Publicado: (2017)

Functional Stability of Plasminogen Activator Inhibitor-1
por: Yasar Yildiz, Songul, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_j7q6kubu35bijprlflemk1udnk